What shall we recommend to the practising physician and the cardiologist in a general hospital?
I have been asked to address the question of what we should tell the physicians in practice today, bearing in mind the facilities and drugs which are presently available. This excludes rt-PA and any of the newer strategies. As I see it, we have four options. First, we can tell physicians to do nothing. Secondly, we can advise them to use intravenous streptokinase. Thirdly, we can suggest they use intracoronary streptokinase or fourthly we can suggest intracoronary or intravenous streptokinase plus PTCA.
KeywordsAcute Myocardial Infarction Dutch Study Practice Today Intravenous Streptokinase Intracoronary Streptokinase
Unable to display preview. Download preview PDF.
- 1.Gruppo Italiano per lo Studio della Streptochinasi nell’ Infarcto Miocardio (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet i:397–402Google Scholar